Eurofins Scientific SE

Eurofins Scientific SE

ERF · PA · Healthcare / Diagnostics & Research

87.98EUR+0.02 (+0.02%)

Price History

Full chart

Market Stats

Previous Close87.96
Open88.12
Day Range87.42 – 88.30
52-Week Range54.22 – 79.22
Volume186.27K
Market Cap12.81B
P/E (TTM)25.99
Forward P/E15.41
EPS2.88
Dividend Yield0.96%
Beta0.85
50-Day Avg72.36
200-Day Avg67.13

About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEODr. Gilles G. Martin Ph.D.
  • Employees65.00K
  • Headquarters23 Val Fleuri, Luxembourg, Luxembourg, 1526, France
  • Websitehttps://www.eurofins.com

Leadership

  • Dr. Gilles G. Martin Ph.D.Chairman of the Board & CEO · b. 1963
  • Ms. Valerie HanoteExecutive Director · b. 1966
  • Mr. Laurent LebrasGroup Administration & CFO
  • Mr. Gonzalo MeleGroup Chief Information Officer
  • Mr. Andrew SwiftHead of Investor Relations
  • Mr. David W. BryantSenior VP of Strategic Business Development North America
  • Mr. Gabriel JuliaSenior VP of Clinical Diagnostics Europe
  • Dr. Timothy S. OostdykExecutive VP of BioPharma, Genomics & Agrosciences Services North America
  • Mr. Joachim ReicheltSenior Vice President of Food & Feed Testing Europe
  • Ms. Yvoine RemySenior Vice President of Environment Testing Europe

Financials

Income Statement

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue161.61M168.68M175.52M233.11M367.99M491.77M632.76M640.07M680.33M828.93M1.04B1.23B1.41B1.95B2.54B2.97B3.78B4.56B5.44B6.72B6.71B6.51B6.95B7.30B
Growth (%)-+4.37%+4.06%+32.81%+57.86%+33.64%+28.67%+1.16%+6.29%+21.84%+25.94%+17.40%+15.07%+38.28%+30.08%+17.14%+27.25%+20.67%+19.20%+23.51%-0.08%-2.94%+6.70%+4.96%
Cost of Revenue66.61M64.86M61.78M83.44M147.91M202.35M251.60M250.75M253.58M294.24M372.26M437.52M493.42M685.15M897.51M1.06B1.35B1.50B1.75B2.15B2.23B5.89B2.24B6.40B
Gross Profit94.99M103.82M113.74M149.66M220.08M289.43M381.15M389.33M426.75M534.69M671.71M788.05M916.80M1.26B1.64B1.91B2.43B3.06B3.69B4.57B4.49B620.40M4.71B896.70M
Gross Margin58.78%61.55%64.80%64.20%59.81%58.85%60.24%60.83%62.73%64.50%64.34%64.30%65.01%64.87%64.62%64.18%64.33%67.05%67.86%68.00%66.82%9.52%67.79%12.29%
Operating Expense90.20M96.49M99.58M119.92M182.77M251.10M339.21M354.12M378.04M446.53M590.20M698.99M815.47M1.13B1.36B1.60B2.08B2.64B2.78B3.29B3.70B73.60M3.99B78.40M
Operating Income4.79M7.33M14.16M29.74M37.31M38.33M41.94M35.20M48.71M88.16M81.50M89.06M101.33M132.36M281.95M303.05M355.81M421.90M906.30M1.28B783.20M546.80M726.20M818.30M
Operating Margin2.97%4.35%8.07%12.76%10.14%7.79%6.63%5.50%7.16%10.64%7.81%7.27%7.19%6.79%11.12%10.20%9.41%9.25%16.66%18.98%11.67%8.39%10.45%11.22%
EBITDA17.38M18.97M26.45M40.80M59.24M67.76M80.92M59.21M91.99M140.56M160.80M185.56M224.12M319.96M477.96M518.14M654.71M859.60M1.28B1.75B1.47B1.22B1.38B1.45B
EBITDA Margin10.75%11.25%15.07%17.50%16.10%13.78%12.79%9.25%13.52%16.96%15.40%15.14%15.89%16.41%18.84%17.44%17.32%18.84%23.59%26.02%21.97%18.68%19.88%19.86%
Net Income139.00K1.61M7.85M12.39M17.51M17.64M17.71M-11.29M23.40M55.41M65.92M72.18M79.10M87.32M174.00M216.77M223.90M195.20M539.40M782.60M610.20M310.30M406.40M475.00M
Net Income Margin0.09%0.96%4.47%5.32%4.76%3.59%2.80%-1.76%3.44%6.68%6.31%5.89%5.61%4.48%6.86%7.30%5.92%4.28%9.92%11.65%9.09%4.76%5.85%6.51%
Interest Expense002.77M4.09M6.50M11.94M17.37M14.87M13.62M17.70M20.23M22.97M31.57M53.49M68.76M55.02M65.62M97.50M103.60M172.60M105.60M129.40M150.80M166.00M
Interest Expense % of Total Revenue0.00%0.00%1.58%1.76%1.77%2.43%2.74%2.32%2.00%2.14%1.94%1.87%2.24%2.74%2.71%1.85%1.74%2.14%1.90%2.57%1.57%1.99%2.17%2.28%

Balance Sheet

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets160.26M166.48M190.13M266.16M460.34M612.02M734.01M659.30M736.16M1.07B1.16B1.50B1.87B3.70B4.13B5.83B7.21B7.82B8.58B9.33B10.08B10.89B10.89B10.98B
Total Liabilities107.35M112.63M124.03M183.75M357.70M396.46M514.89M456.26M505.47M754.26M782.97M1.10B1.21B2.62B2.37B3.35B4.48B4.92B4.86B4.66B5.23B5.75B5.50B7.40B
Total Equity52.88M53.51M65.85M79.57M98.91M203.60M212.59M196.62M225.00M315.46M374.60M387.69M656.48M957.34M1.63B2.44B2.67B2.84B3.69B4.65B4.78B5.08B5.34B3.54B
Cash-2.94M-3.78M36.20M41.24M80.35M64.77M131.67M54.36M107.50M179.49M134.28M297.26M216.62M793.75M826.10M820.36M506.25M297.00M912.40M515.30M486.60M1.22B613.90M791.00M
Total Debt51.47M45.97M63.56M101.47M59.04M36.48M289.74M120.02M276.72M434.68M435.12M684.10M710.23M1.71B1.38B2.22B3.16B3.54B3.15B2.75B3.33B3.93B3.61B5.43B
Net Debt54.41M49.75M27.36M60.23M-21.31M-28.29M158.07M65.66M169.21M255.19M300.84M386.85M493.61M916.28M557.78M1.40B2.65B3.24B2.24B2.24B2.84B2.71B3.00B4.64B

Cash Flow

Currency: EUR2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow11.51M13.18M23.37M25.49M30.18M39.57M60.04M64.34M84.94M110.32M134.16M169.34M212.17M291.15M371.84M405.12M543.89M677.90M1.22B1.51B1.14B1.02B1.32B1.29B
Investing Cash Flow-17.26M-9.54M-19.34M-56.70M-84.34M-108.03M-81.49M-62.96M-48.26M-204.17M-144.39M-189.02M-422.39M-863.52M-391.80M-1.75B-1.56B-439.80M-525.00M-1.03B-855.90M-681.10M-846.50M-1.09B
Financing Cash Flow11.65M-3.41M12.12M33.92M98.06M52.26M89.43M-78.96M6.14M170.67M-40.53M193.97M129.81M1.14B49.90M1.34B691.06M-342.20M-48.60M-910.30M-311.30M413.60M-1.09B13.00M
Capital Expenditure10.35M12.59M9.26M16.89M25.68M48.06M54.80M45.63M41.00M53.91M71.64M99.56M134.52M169.13M199.68M245.74M364.45M425.10M355.50M519.50M660.20M550.10M528.40M760.00M
Free Cash Flow1.16M594.00K14.11M8.60M4.50M-8.49M5.24M18.70M43.94M56.41M62.52M69.78M77.65M122.02M172.17M159.39M179.45M252.80M868.00M990.30M476.10M467.80M790.50M535.00M
Dividends Paid---3.00K484.00K1.87M2.56M1.42M1.42M2.86M12.06M15.48M18.31M20.41M22.45M34.91M42.60M51.40M500.00K130.40M192.50M191.90M95.60M110.00M
FCF to OCF10.04%4.51%60.37%33.74%14.91%-21.46%8.73%29.07%51.73%51.14%46.60%41.21%36.60%41.91%46.30%39.34%32.99%37.29%70.94%65.59%41.90%45.96%59.94%41.31%
Dividend Paid to FCF---0.03%10.75%-22.05%48.86%7.57%3.23%5.07%19.29%22.19%23.59%16.73%13.04%21.90%23.74%20.33%0.06%13.17%40.43%41.02%12.09%20.56%

Earnings

Report DateSep 30, 2001Dec 31, 2001Feb 14, 2005May 13, 2005Aug 30, 2005Nov 15, 2006Feb 28, 2007May 14, 2007Aug 31, 2007Nov 15, 2007Mar 5, 2008Aug 29, 2008Nov 13, 2008Mar 5, 2009May 14, 2009Aug 31, 2009Nov 12, 2009Mar 3, 2010May 11, 2010Aug 30, 2010Nov 8, 2010Feb 28, 2011May 9, 2011Aug 30, 2011Nov 7, 2011Mar 5, 2012Aug 30, 2012Mar 4, 2013Nov 4, 2013Mar 3, 2014Aug 28, 2014Mar 2, 2015Aug 31, 2015Feb 29, 2016Aug 2, 2016Oct 21, 2016Feb 28, 2017Apr 25, 2017Aug 30, 2017Oct 24, 2017Mar 6, 2018Apr 27, 2018Jul 31, 2018Oct 23, 2018Mar 5, 2019Apr 26, 2019Aug 29, 2019Oct 28, 2019Mar 4, 2020Apr 28, 2020Aug 6, 2020Oct 22, 2020Mar 1, 2021Apr 28, 2021Aug 5, 2021Oct 21, 2021Jan 6, 2022Apr 21, 2022Jul 27, 2022Oct 18, 2022Mar 1, 2023Apr 26, 2023Jul 26, 2023Oct 24, 2023Feb 27, 2024Apr 24, 2024Jul 24, 2024Oct 22, 2024Jan 30, 2025Apr 23, 2025Jul 24, 2025Oct 21, 2025Dec 31, 2025Jan 28, 2027
EPS Estimate--0.03-0.020.030.060.020.04-0.07---------0.07---0.10---0.000.000.000.000.000.000.000.00-0.005.550.00-0.00-0.00-0.006.640.0011.370.00-0.0015.500.00-0.00-0.00-0.001.810.001.090.001.160.001.250.001.630.001.910.00--
EPS Actual-0.00-0.000.050.010.020.020.060.000.020.030.070.030.020.07-0.02-0.000.04-0.09-0.020.040.070.060.010.080.120.150.090.170.000.000.000.000.000.000.000.007.410.006.390.0010.260.008.400.0011.120.008.470.009.530.008.860.002.500.002.810.001.090.001.900.001.560.001.070.001.150.001.250.001.630.001.160.001.22-
Surprise--66.67%-0.00%-33.33%0.00%-99.50%-58.75%-2.43%---------3.29%---15.90%-------------15.14%-------27.56%--16.18%----83.87%--------13.81%--1.83%--0.86%-0.00%-0.00%--39.27%---
Timing--Pre-marketPre-marketPre-marketPre-marketAfter-hours-----------------After-hours------After-hoursPre-marketPre-marketPre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-Pre-market-After-hours-Pre-market-Pre-market---Pre-market-Pre-market--Pre-market

Key Statistics & Ratios

Market Cap12.81B
Enterprise Value16.89B
Trailing P/E25.99
Forward P/E15.41
PEG Ratio0.92
Price / Sales1.73
Price / Book2.82
EPS2.88
Book Value20.85
Revenue (TTM)7.39B
Gross Profit (TTM)1.71B
EBITDA1.54B
Profit Margin7.17%
Operating Margin16.17%
Return on Equity11.33%
Return on Assets5.99%
Shares Outstanding171.11M
Shares Float110.07M
Beta0.85
Dividend Yield0.96%
Dividend Rate0.72
Payout Ratio25.00%

Dividends

20261×
0.72Apr 28, 2026
20251×
0.60Apr 28, 2025
20241×
0.50Jul 3, 2024
20231×
1.00Jul 4, 2023
20221×
1.00Jul 5, 2022
20211×
0.68Jul 1, 2021
20191×
0.29Jul 3, 2019
20181×
0.24Jun 28, 2018
20171×
0.20Jun 29, 2017
20161×
0.14Jun 29, 2016
20151×
0.13Jun 29, 2015
20141×
0.12Jun 27, 2014
20131×
0.10Jul 5, 2013
20121×
0.08Apr 3, 2012
20111×
0.02Jun 14, 2011
20102×
0.10Sep 27, 20100.01Jul 8, 2010
20091×
0.01Jun 29, 2009
20081×
0.01Jul 21, 2008
20071×
0.01Jul 26, 2007

Stock Splits

  • Nov 19, 202010:1
  • May 22, 200010:1
  • Sep 14, 1999847:834
  • Jun 9, 1998772:739